医療法人社団裕健会 神田クリニック
Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.
The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →
Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive
02C2407047 +3Location
- Prefecture
- Tokyo
- Address
- 千代田区内神田2-4-1 神田メディカルビル 2F-8F
Plan classification
- Class INot registered
- Class IIThe medium-risk category under the law.
- Class IIINot registered
Certified committee for regenerative medicine
- 日本再生医療協会特定認定再生医療等委員会
Public score
57.4/ 100
- A · Review level
- 25.0 / 30
- B · Technologies
- 18.5 / 35
- C · Coverage
- 7.1 / 25
- D · Class I / II technologies
- 6.7 / 10
The public score is calculated from public registration information and does not reflect quality of care. Scoring method →
Registered technologies (4)
Stem cells (all sources) 4
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自己脂肪由来幹細胞を用いた慢性疼痛の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己脂肪由来幹細胞を用いた変形性関節症の治療 | Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletal | Class II |
| 自己脂肪由来幹細胞を用いた糖尿病の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| アレルギー性疾患に対する自己脂肪由来幹細胞による治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
Adipose-derived stem cells 4
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自己脂肪由来幹細胞を用いた慢性疼痛の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己脂肪由来幹細胞を用いた変形性関節症の治療 | Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletal | Class II |
| 自己脂肪由来幹細胞を用いた糖尿病の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| アレルギー性疾患に対する自己脂肪由来幹細胞による治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
Joints and musculoskeletal 1
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自己脂肪由来幹細胞を用いた変形性関節症の治療 | Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletal | Class II |
Certified committee for regenerative medicine
- 日本再生医療協会特定認定再生医療等委員会
Public document number
02C240704702C260100702C260101301C2604045
Plan classification · Certified committee for regenerative medicine · Public document number
| Registered technologies | Plan classification | Certified committee for regenerative medicine | Public document number |
|---|---|---|---|
| 自己脂肪由来幹細胞を用いた慢性疼痛の治療 | Class II | 日本再生医療協会特定認定再生医療等委員会 | 02C2407047 |
| 自己脂肪由来幹細胞を用いた変形性関節症の治療 | Class II | 日本再生医療協会特定認定再生医療等委員会 | 02C2601007 |
| 自己脂肪由来幹細胞を用いた糖尿病の治療 | Class II | 日本再生医療協会特定認定再生医療等委員会 | 02C2601013 |
| アレルギー性疾患に対する自己脂肪由来幹細胞による治療 | Class II | 日本再生医療協会特定認定再生医療等委員会 | 01C2604045 |
Other institutions in the same prefecture
- GINZA AYUMi CLINICPublic score 57.4
- MediLotus clinicPublic score 57.4
- アーモンドクリニックPublic score 57.4
- アウラニクリニックPublic score 57.4
- センチュリークリニック東京Public score 57.4
- 医療法人社団 東京DタワーホスピタルPublic score 57.4
- 医療法人社団白慈会 白金坂の上診療所Public score 57.4
- 一般社団法人健寿会 表参道イーグルクリニックPublic score 57.4